R****i
发帖数: 1 | | l********4
发帖数: 33 | 2 "The update that likely most rattled investors was that Editas' chief
scientific officer, Charles Albright, is leaving the company to pursue
another opportunity."
不过涨跌其实都不需要理由的。之前涨太多了，找个借口回调而已，呵呵：） | R****i
发帖数: 1 | 3 Editas Medicine Announces the FDA has Cleared Initiation of the EDIT-301
Clinical Trial
【在 l********4 的大作中提到】
: "The update that likely most rattled investors was that Editas' chief
: scientific officer, Charles Albright, is leaving the company to pursue
: another opportunity."
: 不过涨跌其实都不需要理由的。之前涨太多了，找个借口回调而已，呵呵：）
| p*********g
发帖数: 9527 | 4 CSO离职了
【在 R****i 的大作中提到】
: 消息不错呀
|
|
